Oppenheimer analyst Brian Nagel maintained a Buy rating on Petiq (NASDAQ:PETQ) Inc on Tuesday, setting a price target of $50, which is approximately 16.50% above the present share price of $42.92.
Nagel expects Petiq Inc to post earnings per share (EPS) of -$0.41 for the second quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in Petiq, with an average price target of $41.3.
The analysts price targets range from a high of $50 to a low of $33.04.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $164.21 million and a net profit of -$4.05 million. The company's market cap is $1.25 billion.
According to TipRanks.com, Oppenheimer analyst Brian Nagel is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 36.9% and a 77.66% success rate.
PetIQ , Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segments produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.